9-cis-retinoic acid tritiated at the 11,12 position. It is a form of vitamin A and activates retinoic acid receptors (RARs).
You successfully added item(s) to your cart
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
9-cis-retinoic acid is a vitamin A derivative that binds both retinoid X receptors (RXRs) and retinoic acid receptors (RARs). These are nucelar receptors that can also act as transcription factors. 9-cis-retinoic acid is used in medicine as an anti-cancer agent, and is used topically to treat skin lesions and chronic eczema.
We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.
Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, PerkinElmer has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.
References for NET1151:
|Label Position||Specifically Labeled|
|Product Brand Name||NEN Radiochemicals|
|Receptor Type||Retinoic Acid Receptors|
|Shipping Condition||Dry Ice|
|Special Ordering Information||This is a radioactive product - shipping address must have a license to receive radioactive materials.|
|Therapeutic Area||Angiogenesis, Metabolic Disorders, Cancer|
|Unit Size||50 µCi|